{"product_id":"naplex-oncology-review-soleil-pharmacy-boards-prep™","title":"NAPLEX Oncology Review — Soleil Pharmacy Boards Prep™","description":"\u003ch2\u003eMaster Oncology Pharmacotherapy for the NAPLEX\u003c\/h2\u003e\u003cp\u003eThe \u003cstrong\u003eNAPLEX Oncology Review\u003c\/strong\u003e covers the high-yield cancer pharmacotherapy principles tested on the NAPLEX. From chemotherapy mechanisms to supportive care management, this guide prepares you to apply oncology drug knowledge with clinical confidence.\u003c\/p\u003e\u003ch3\u003eTopics Covered\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemotherapy Mechanisms:\u003c\/strong\u003e alkylating agents, antimetabolites, topoisomerase inhibitors, mitotic inhibitors, platinum compounds\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTargeted Therapy:\u003c\/strong\u003e tyrosine kinase inhibitors, monoclonal antibodies, CDK4\/6 inhibitors, PARP inhibitors\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunotherapy:\u003c\/strong\u003e checkpoint inhibitors (PD-1, PD-L1, CTLA-4), CAR-T therapy, immune-related adverse events\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHormone Therapy:\u003c\/strong\u003e breast cancer (tamoxifen, aromatase inhibitors), prostate cancer (ADT, enzalutamide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHematologic Malignancies:\u003c\/strong\u003e ALL, AML, CLL, CML, multiple myeloma, lymphoma treatment regimens\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSolid Tumor Pharmacotherapy:\u003c\/strong\u003e lung, breast, colorectal, prostate, ovarian cancer — standard of care regimens\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupportive Care:\u003c\/strong\u003e antiemetics (CINV), G-CSF, erythropoiesis-stimulating agents, bisphosphonates\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemotherapy Toxicities:\u003c\/strong\u003e cardiotoxicity, nephrotoxicity, neurotoxicity, myelosuppression management\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose Modifications:\u003c\/strong\u003e renal and hepatic impairment adjustments for chemotherapy agents\u003c\/li\u003e\n\u003cli\u003eHigh-yield drug tables and treatment algorithm summaries throughout\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eSoleil Scientific Rating™\u003c\/h3\u003e\u003cp\u003e⭐⭐⭐⭐⭐ — \u003cem\u003eOncology pharmacotherapy is complex but high-yield. Master the mechanisms and the toxicities and the NAPLEX questions become manageable.\u003c\/em\u003e\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAdvancing Science. Empowering People. — Soleil Scientific Group\u003c\/strong\u003e\u003c\/p\u003e","brand":"Soleil Scientific Group","offers":[{"title":"Default Title","offer_id":55018311647604,"sku":null,"price":69.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.soleilscientificgroup.com\/products\/naplex-oncology-review-soleil-pharmacy-boards-prep%e2%84%a2","provider":"Soleil Scientific Group","version":"1.0","type":"link"}